The NICE Lipid Modification guideline (CG67) has been amended so that the Framingham risk equation is no longer the equation of choice for the assessment of cardiovascular disease (CVD) risk. The guideline now states that the QRISK or ASSIGN equations as well as the Framingham equation can be used to calculate the CVD risk. There are no changes to the categories of risk recommended for treatment or in whom the equations should be used to calculate the risk.
Click to search or browse MIMS
The most up-to-date drug information at your fingertips.
- Get the prescribing support you need.
- Register today for full access to the MIMS database, plus tables and guideline summaries, new and deleted products and consultation tools.